Filing Details
- Accession Number:
- 0001209191-22-053530
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-12 20:51:16
- Reporting Period:
- 2022-10-12
- Accepted Time:
- 2022-10-12 20:51:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1697532 | Applied Therapeutics Inc. | APLT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1775490 | Shoshana Shendelman | C/O Applied Therapeutics, Inc. 545 Fifth Avenue, Suite 1400 New York NY 10017 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-10-12 | 38,153 | $0.52 | 644,239 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,750,000 | Indirect | See footnote |
Common Stock | 1,492,094 | Indirect | See footnote |
Common Stock | 709,720 | Indirect | See footnote |
Common Stock | 290,280 | Indirect | See footnote |
Common Stock | 88,397 | Indirect | See footnote |
Footnotes
- These shares were purchased by Dr. Shendelman in multiple transactions.
- Weighted average price. These shares were purchased by Dr. Shendelman in multiple transactions at prices ranging from $0.504 to $0.537 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Through a grantor retained annuity trust.
- Through a family trust controlled by the reporting person's spouse.
- Through the reporting person's spouse.
- Through a family trust controlled by the reporting person.
- Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.